Deals
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
Acrivon Therapeutics to Advance Proteomics Platform & Oncology Pipeline with $100M Series B Financing
2021-11-12
LATEST
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115